On 4 February 2026, Glory Health Industry Limited (Incorporated in the Cayman Islands with limited liability; stock code: 02329) released its monthly return for the period ended 31 January 2026. The announcement indicates that the authorized share capital remains at HKD 10,000,000, represented by 10,000,000,000 ordinary shares at a par value of HKD 0.001 each, with no changes from the preceding month.

By the close of January 2026, total issued shares stood at 4,444,417,986, with no treasury shares and no reported movements. The public float requirement of 15% was confirmed to be met, and there were no newly issued securities, repurchases, or convertibles during the reporting period.